Alyeska Investment Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-148,149
Closed -$26.2M 542
2022
Q2
$26.2M Sell
148,149
-90,824
-38% -$13.1M 0.3% 110
2022
Q1
$34.4M Buy
238,973
+117,483
+97% +$15.9M 0.38% 89
2021
Q4
$18.8M Sell
121,490
-105,570
-46% -$17.7M 0.22% 139
2021
Q3
$38.6M Buy
227,060
+95,244
+72% +$14.8M 0.48% 65
2021
Q2
$20.8M Buy
+131,816
New +$19.6M 0.24% 125
2018
Q3
Sell
-264,616
Closed -$17.6M 532
2018
Q2
$17.6M Buy
+264,616
New +$15.2M 0.16% 162

Other funds holding SGEN

Alyeska Investment Group's SGEN Position: Q3 2022 in Review

Alyeska Investment Group sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 148,149 shares — an estimated $26.2M sold.

Alyeska Investment Group first reported a position in SGEN in Q2 2018 and held it in 6 quarters. The position peaked at $38.6M in Q3 2021. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Alyeska Investment Group reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 148,149 Seagen Inc. Common Stock shares in Q3 2022, an estimated $26.2M.
  • Alyeska Investment Group first reported a position in Seagen Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Alyeska Investment Group's Seagen Inc. Common Stock position peaked at $38.6M in Q3 2021.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.